(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study.
Pietro TiraboschiAngelo CorsoUgo Paolo GuerraFlavio NobiliArnoldo PiccardoMaria Lucia CalcagniDuccio VolterraniDiego CecchinMauro TettamantiLuigi AntelmiSimone VidaleLeonardo SaccoMaria MerelloStefano StefaniniAnna MicheliPaola VaiSelene CapitanioSara Vincenzina GabanelliRiccardo RivaPatrizia PintoAve Maria BiffiCristina Muscionull nullPublished in: Annals of neurology (2016)
(123) I-FP-CIT SPECT and (123) I-MIBG myocardial scintigraphy have similar sensitivity for detecting DLB, but the latter appears to be more specific for excluding non-DLB dementias, especially when parkinsonism is the only "core feature" exhibited by the patient. Our data also indicate that the potential confounding effects of diabetes and heart disease on (123) I-MIBG myocardial scintigraphy results might have been overestimated. Ann Neurol 2016;80:368-378.
Keyphrases
- pet ct
- left ventricular
- computed tomography
- parkinson disease
- type diabetes
- cardiovascular disease
- positron emission tomography
- mild cognitive impairment
- machine learning
- contrast enhanced
- pulmonary hypertension
- heart failure
- deep learning
- case report
- electronic health record
- climate change
- magnetic resonance
- atrial fibrillation
- skeletal muscle
- image quality
- weight loss